Cochlear share price clings to 52-week low after broker warning on Nexa rollout — what investors watch next
Cochlear Ltd shares closed down 0.34% at A$199.81 Tuesday, near a 52-week low and 37% below their yearly peak, as investors remained wary over delays in the Nucleus Nexa implant rollout. The company forecast FY26 profit at the low end of guidance and warned a weak Australian dollar could cut profit by A$30 million.
